PHIA Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €25.30 |
| 52 Week High | €27.00 |
| 52 Week Low | €16.73 |
| Beta | 0.78 |
| 1 Month Change | 34.43% |
| 3 Month Change | 28.67% |
| 1 Year Change | 38.81% |
| 3 Year Change | -44.72% |
| 5 Year Change | -27.51% |
| Change since IPO | -24.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHIA | AT Medical Equipment | AT Market | |
|---|---|---|---|
| 7D | 28.9% | -1.3% | -0.1% |
| 1Y | 38.8% | -0.5% | 5.7% |
Return vs Industry: PHIA exceeded the Austrian Medical Equipment industry which returned 1% over the past year.
Return vs Market: PHIA exceeded the Austrian Market which returned 5.6% over the past year.
Price Volatility
| PHIA volatility | |
|---|---|
| PHIA Average Weekly Movement | 11.5% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in AT Market | 5.0% |
| 10% least volatile stocks in AT Market | 1.7% |
Stable Share Price: PHIA's share price has been volatile over the past 3 months.
Volatility Over Time: PHIA's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| PHIA fundamental statistics | |
|---|---|
| Market cap | €22.83b |
| Earnings (TTM) | -€794.00m |
| Revenue (TTM) | €18.14b |
1.3x
P/S Ratio-28.8x
P/E RatioIs PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHIA income statement (TTM) | |
|---|---|
| Revenue | €18.14b |
| Cost of Revenue | €10.63b |
| Gross Profit | €7.51b |
| Other Expenses | €8.30b |
| Earnings | -€794.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 29, 2024
| Earnings per share (EPS) | -0.88 |
| Gross Margin | 41.38% |
| Net Profit Margin | -4.38% |
| Debt/Equity Ratio | 63.8% |
How did PHIA perform over the long term?
See historical performance and comparison